
Purpose Conserv Incm
Purpose Conserv Incm (TSE:PRP) Price & Chart
TSE:PRP ETF Chart & Stats
- Day’s Range
- CAD 20.57 - CAD 20.57
- 52-Week Range
- CAD 19.51 - CAD 21.47
- Previous Close
- CAD 20.90
- Volume
- 100
- Average Volume (3M)
- 390
- AUM
- 1.03M
- NAV
- 20.51
- Expense Ratio
- 1.04%
- Holdings Count
- 151
- Beta
- 0.25
- Inception Date
- Oct 21, 2016
- Last Dividend Ex-Date
- Oct 28, 2026
- Dividend Yield
- (3.50%)
- Shares Outstanding
- 50,000
- Standard Deviation
- N/A
ETF Overview
Purpose Conserv Incm
Purpose Conserv Incm, trading under the ticker TSE:PRP, is a meticulously designed exchange-traded fund (ETF) that embodies a strategic approach to asset allocation with a keen focus on achieving specific target outcomes within the income niche. This ETF is tailored for investors seeking a balanced blend of stability and income generation, making it an ideal choice for those prioritizing consistent returns over aggressive growth. Purpose Conserv Incm distinguishes itself by its commitment to conservative income strategies, strategically allocating assets across diverse classes to mitigate risk while optimizing income potential. The fund's approach is underpinned by a disciplined focus on generating reliable income streams, making it particularly appealing to income-focused investors such as retirees or those looking for steady cash flow. What sets TSE:PRP apart is its innovative structure that combines traditional income-generating assets with dynamic allocation techniques. This ensures that the fund remains resilient in varying market conditions, offering a level of predictability and security uncommon in many income-focused investment vehicles. Investors in Purpose Conserv Incm can anticipate a well-curated portfolio that balances fixed-income securities with other income-producing assets, all meticulously selected to align with the fund's overarching goal of delivering stable income. This ETF promises a harmonious blend of income generation and risk management, making it a compelling option for those seeking to secure and enhance their financial future through prudent investment choices.
- Asset Class
- Asset Allocation
- Region
- Global
- Issuer
- Purpose
- Index Tracked
- No Underlying Index
- Ticker Symbol
- TSE:PRP
TSE:PRP ETF News



Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie’s official study, “A Post-marketing Non-interventional Study for Upadacitinib in Patients With Moderately to Severely Active Crohn’s Disease












